Bioequivalence Regulation Data Characteristics
Bioequivalence (BE) regulation data originates from regulations, guidelines, and technical review standards published by national drug regulatory agencies, as well as submission documents from pharmaceutical companies. This data updates relatively stably, typically with revisions released following regulatory policy adjustments or technological advancements. Document structures primarily consist of normative files, such as technical guidance principles and review rules, often in PDF or Word format. These documents contain numerous tables, figures, and specialized terminology. Key fields include trial design requirements, statistical analysis methods, subject selection criteria, biological sample testing indicators (e.g., Cmax, AUC), judgment criteria (e.g., 90% confidence interval), and exemption conditions or special considerations for specific drugs. Units are frequently international standard units, such as mg/L, h, ng/mL.
Constraints from Bioequivalence Regulation Data on Tool Calling and Plugins
The standardized and specialized nature of bioequivalence regulation data demands high precision and contextual understanding from tool calling and plugins. The extensive use of tables and figures in documents presents a challenge for information extraction tools in structured recognition and parsing. The frequent occurrence of specialized terminology and abbreviations requires vocabulary support or domain ontologies to ensure accurate semantic understanding. Calling judgment criteria and statistical analysis methods may involve external calculation tools or predefined logic to prevent the model from directly generating numerical judgments. Additionally, due to the periodic updates of regulations, plugins need version management capabilities to ensure they always reference the latest and most authoritative regulatory content. Strict validation of key indicator units is crucial to prevent misinterpretation and erroneous output.
Configuration Recommendations
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Knowledge Base Chunking Strategy | Smart chunking by title, paragraph | Regulatory documents have clear structures; chunking by logical units improves recall precision. |
Chunk Length | 800–1200 characters | Balances paragraph completeness with model input limits, reducing context loss. |
Similarity Threshold | 0.82–0.88 | Ensures recalled content is highly relevant to the query, excluding irrelevant regulatory clauses. |
Recall Count | Top 5 | Balances recall breadth with model processing efficiency; critical information is usually concentrated in the first few items. |
Reranked Return Count | Top 3 | Further refines results, prioritizing the most relevant regulatory clauses. |
Tool Calling Timeout | 600 seconds | Accommodates complex calculations or slow external API responses, preventing task interruption. |
Common Pitfalls
- When multiple AI models are called in a workflow, the final output includes redundant information from intermediate AI models. This occurs because the intermediate AI model was not correctly configured to act solely as an internal processing step, and its output was not suppressed.
- Numerical or judgment results returned after tool calling do not comply with regulatory requirements, such as an incorrect confidence interval calculation. This happens due to inaccurate parameter mapping for tool calls or external calculation logic not strictly adhering to bioequivalence statistical standards.
- When a user asks about exemption conditions for a specific drug, the tool fails to correctly call the knowledge base and provide an answer. This is because the knowledge base chunking failed to identify exemption clauses within tables or lists, leading to incomplete recall.
How to Verify Configuration
- Simulate user queries for typical bioequivalence regulation questions to check if the system accurately calls relevant regulatory provisions or calculation tools.
- Verify that the calculation results of key indicators (e.g., 90% confidence intervals for Cmax, AUC) after tool calling align with known regulatory examples or standard values.
- Check if the knowledge base results include all critical information required by the query, such as trial design requirements and statistical analysis methods, and confirm no redundant or irrelevant content.
- Trace logs to confirm that the sequence of tool calls and parameter passing conforms to expectations when handling complex problems, and that no timeouts or error codes occur.
The values provided are common starting points and should be measured against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.